Nutter attorney files an amicus brief on behalf of BioIndustryPrint PDF
Konstantin Linnik, a member of the firm’s Intellectual Property Department and Life Sciences practice group, represented the BioIndustry Association in an amicus brief filing at the U.S. Court of Appeals for the Federal Circuit in a widely publicized case, Ariosa v. Sequenom. The earlier panel of the Federal Circuit held that Sequenom’s patent was invalid under Section 101 of the U.S. Patent Code as directed to patent-ineligible subject matter.
BioIndustry is a UK-based trade association of over 300 member organizations working in R&D and manufacturing in the bioscience sector. BioIndustry is supporting Sequenom’s petition for rehearing the case by the full court. While the case concerns subject matter eligibility for diagnostic methods, it has broader implications for biotechnology inventions in general. Eleven other amici briefs were filed, reflecting the high importance of this case to the industry and the patent system.
To read the amicus brief, click here.